1. Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial. Issue 10090 (8th July 2017) Authors: Vermeire, Séverine; Sandborn, William J; Danese, Silvio; Hébuterne, Xavier; Salzberg, Bruce A; Klopocka, Maria; Tarabar, Dino; Vanasek, Tomas; Greguš, Miloš; Hellstern, Paul A; Kim, Joo Sung; Sparrow, Miles P; Gorelick, Kenneth J; Hinz, Michelle; Ahmad, Alaa; Pradhan, Vivek; Hassan-Zahraee, Mina;... Journal: Lancet Issue: Volume 390:Issue 10090(2017) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn's Disease. (7th September 2017) Authors: Hassan-Zahraee, Mina; Banerjee, Anindita; Cheng, John B; Zhang, Weidong; Ahmad, Alaa; Page, Karen; von Schack, David; Zhang, Baohong; Martin, Steven W; Nayak, Satyaprakash; Reddy, Padma; Xi, Li; Neubert, Hendrik; Fernandez Ocana, Mireia; Gorelick, Ken; Clare, Robert; Vincent, Michael; Cataldi, Fa... Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of drug–drug interaction potential with EDP‐305, a farnesoid X receptor agonist, in healthy subjects. Issue 9 (24th June 2022) Authors: Ahmad, Alaa; Adda, Nathalie Journal: Clinical and translational science Issue: Volume 15:Issue 9(2022) Page Start: 2146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Derivation of Phase 3 dosing for peginterferon lambda‐1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates. (24th July 2014) Authors: Wang, Xiaodong; Hruska, Matthew; Chan, Phyllis; Ahmad, Alaa; Freeman, Jeremy; Horga, Maria Arantxa; Hillson, Jan; Kansra, Vikram; Lopez‐Talavera, Juan‐Carlos Journal: Journal of clinical pharmacology Issue: Volume 55:Number 1(2015:Jan.) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Derivation of Phase 3 dosing for peginterferon lambda‐1a in chronic hepatitis C, Part 2: Exposure–response analyses for efficacy and safety variables. (24th July 2014) Authors: Hruska, Matthew; Wang, Xiaodong; Chan, Phyllis; Ahmad, Alaa; Freeman, Jeremy; Horga, Maria Arantxa; Hillson, Jan; Kansra, Vikram; Lopez‐Talavera, Juan‐Carlos Journal: Journal of clinical pharmacology Issue: Volume 55:Number 1(2015:Jan.) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B. Issue 6 (16th November 2022) Authors: Feld, Jordan J; Lawitz, Eric; Nguyen, Tuan; Lalezari, Jacob; Hassanein, Tarek; Martin, Paul; Han, Steven-Huy; Dieterich, Douglas; Giard, Jeanne-Marie; De La Rosa, Guy; Ahmad, Alaa; Luo, Ed; Conery, Annie L; Adda, Nathalie Journal: Antiviral therapy Issue: Volume 27:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EDP‐297: A novel, farnesoid X receptor agonist—Results of a phase I study in healthy subjects. Issue 2 (21st November 2022) Authors: Marotta, Christine; Ahmad, Alaa; Luo, Ed; Oosterhaven, Jart; van Marle, Sjoerd; Adda, Nathalie Journal: Clinical and translational science Issue: Volume 16:Issue 2(2023) Page Start: 338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study. (16th September 2017) Authors: D'Haens, Geert; Vermeire, Séverine; Vogelsang, Harald; Allez, Matthieu; Desreumaux, Pierre; Van Gossum, Andre; Sandborn, William J; Baumgart, Daniel C; Ransohoff, Richard M; Comer, Gail M; Ahmad, Alaa; Cataldi, Fabio; Cheng, John; Clare, Robert; Gorelick, Kenneth J; Kaminski, Annamarie; Pradhan, ... Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 2(2018:Feb.) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study. Issue 10 (5th October 2017) Authors: Sandborn, William J; Lee, Scott D; Tarabar, Dino; Louis, Edouard; Klopocka, Maria; Klaus, Jochen; Reinisch, Walter; Hébuterne, Xavier; Park, Dong-Il; Schreiber, Stefan; Nayak, Satyaprakash; Ahmad, Alaa; Banerjee, Anindita; Brown, Lisa S; Cataldi, Fabio; Gorelick, Kenneth J; Cheng, John B; Hassan-... Journal: Gut Issue: Volume 67:Issue 10(2018) Page Start: 1824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Randomized Study of Asunaprevir plus Pegylated Interferon-α and Ribavirin for Previously Untreated Genotype 1 Chronic Hepatitis C. Issue 7 (October 2013) Authors: Bronowicki, Jean-Pierre; Pol, Stanislas; Thuluvath, Paul J; Larrey, Dominique; Martorell, Claudia T; Rustgi, Vinod K; Morris, David W; Younes, Ziad; Fried, Michael W; Bourlière, Marc; Hézode, Christophe; Reddy, K Rajender; Massoud, Omar; Abrams, Gary A; Ratziu, Vlad; He, Bing; Eley, Timothy; Ahma... Journal: Antiviral therapy Issue: Volume 18:Issue 7(2013) Page Start: 885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗